Metabolomics for molecular phenotyping in respiratory disease

C. Wheelock (Stockholm, Sweden)

Source: ERS Lung Science Conference 2016
Number: 25

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Wheelock (Stockholm, Sweden). Metabolomics for molecular phenotyping in respiratory disease. ERS Lung Science Conference 2016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Integrating fingerprints: molecular phenotyping of severe asthma
Source: International Congress 2015 – Fingerprinting severe asthma
Year: 2015

Omics in population studies: a molecular epidemiology perspective in chronic airway disease
Source: International Congress 2014 – Personalised exposure and gene environment interactions in chronic airway disease: the exposome and epigenome
Year: 2014

Evolution and respiratory genetics
Source: Annual Congress 2006 - Genes, environment and the lung
Year: 2006

Applying clinical metagenomics for the detection and characterisation of respiratory infections
Source: Eur Respir Monogr 2019; 83: 35-49
Year: 2019

Non-targeted integrative multi-omics approaches on sputum reveal potential diagnostic and monitoring biomarkers for respiratory diseases
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017

High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications
Source: Eur Respir J 2009; 33: 489-506
Year: 2009

From genetical genomics to system genetics: application in asthma/COPD
Source: ERS Research Seminar 2015
Year: 2015

Application of omics technologies to the identification of biomarkers for COPD
Source: Annual Congress 2007 - Cell biology of asthma and COPD
Year: 2007

The airway ‘resistome’ in chronic respiratory disease: a metagenomics approach
Source: International Congress 2019 – The microbiome: novel data across respiratory diseases
Year: 2019

Application of ’omics technologies to biomarker discovery in inflammatory lung diseases
Source: Eur Respir J 2013; 42: 802-825
Year: 2013

Metabolic profiling of severe asthma: implications for phenotyping and treatment
Source: ERS Lung Science Conference 2020
Year: 2020

Integrating systems biology in respiratory diseases
Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research
Year: 2016

The molecular and clinical diseasomeof comorbid diseases inchronic obstructive pulmonary disease
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015

Proteomic research tools for respiratory medicine
Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow
Year: 2008

Metabolomic fingerprinting in the identification of biomarkers in COPD patients
Source: Annual Congress 2012 - Basic and translational studies in COPD
Year: 2012

To the molecular genetic mechanisms of the COPD pathogenesis
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018

Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014